Test of nitroglycerin safety with study drug nurandociguat in heart disease
Treatments studied
Part of Heart & circulation clinical trials.
This study checks if a new drug called nurandociguat is safe to take with nitroglycerin for people with stable coronary artery disease. It will help doctors understand how the combination affects the body.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 40 and 80 years old.
- You have stable coronary artery disease (blockages in heart arteries that are not getting worse quickly).
- Your kidneys work well enough (eGFR at least 30).
- You weigh at least 132 pounds (60 kg) and have a body mass index between 18 and 36.
- Your heart's pumping ability (ejection fraction) is 30% or higher.
- You do not have any serious heart valve problems, recent stroke, or lung disease like COPD or asthma.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an experimental drug (RO7763505) in healthy people and people with stable heart disease. It aims to see how safe the drug is and how it works in the body.
This study compares two ways of testing the small blood vessels in the heart to understand chest pain when no major blockages are found. It may help doctors learn more about why you have chest pain and how to treat it.
This trial studies whether a medicine (nicorandil) given into a coronary artery during stent procedures can help keep blood flow from getting worse. It may help people having stent placement for coronary artery disease by improving how well blood moves through the treated area.
This study tests a new form of the drug nurandociguat tablet to see how well it is absorbed compared to the old tablet, and whether food changes how it works. Healthy volunteers are needed to take the tablets and have their blood levels checked.
This trial tests a new medicine called UDP-003 in two groups: healthy volunteers and people who had a heart event (acute coronary syndrome) at least a year ago. The goal is to see if the drug is safe and how the body handles it, which could lead to better treatments for heart disease.
This trial tests whether taking a simple nitrate supplement (similar to the nitrates in beets) can improve blood flow in the tiny vessels of the heart for women who have chest pain but no blockages in their major arteries. It may help if your heart's small vessels aren't working as well as they should.
Hear when a new Stable Coronary Artery Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.